Age and Sex Differences in Incident Thrombosis in Patients Hospitalized with COVID-19
Analysis is done between age and sex and outcomes of thrombosis in patients hospitalized with COVID. Men had higher incidence of thrombosis (19% vs.12%) than women. Sex differences in thrombotic risk were highest in the young individuals and reduced with older age. It was concluded that men hospitalized have a greater risk than women and sex differences were most pronounced among younger patients.
Cryoablation Versus Antiarrhythmic Drug Therapy as Initial Treatment for Atrial Fibrillation
Researchers evaluated changes in quality of life (QOL) with cryoablation vs antiarrhythmic drug (AAD) therapy in the STOP atrial fibrillation (AF) First study. Cryoablation showed substantially higher improvement in the AF Effect on Quality of life summary and domain scores as compared to AAD group. It was concluded that first line cryoablation is superior to AAD.
Dose Triple Medication Pill: RADIANCE-HTN Trial
The study aimed to analyse blood pressure lowering effect in patients with resistant hypertension. Renal denervation (RDN) group showed reduction in daytime ambulatory systolic BP (DASBP) by -9.7 mmHg vs -3.0 mmHg in the sham group. It was concluded that ultrasound RDN safely decreased BP in patients with hypertension resistant to a standardized single pill combination of 3 medicines.
VOYAGER PAD Trial
Bauersachs RM presented findings from the VOYAGER PAD trial that analysed the number of first and total events in peripheral artery disease (PAD) patients undergoing lower extremity revascularization (LER), including all limb and cardiovascular (CV) events and the efficacy of Rivaroxaban on events. Rivaroxaban 2.5 mg twice daily with Aspirin reduces adverse limb and CV events.
